1Interpretations of Chinese Society of Clinical Oncology Breast Cancer Guideline version 2022 UpdatesSUN Zhengkui, JIANG Zefei212-2182Interpretation of the essential updates in Chinese Society of Breast Surgery Practice Guideline 2022XIANG Hongyu, LIU Yinhua219-2233Update and interpretation of the 2022 Guidelines for the Diagnosis and Treatment of Prostate Cancer by Chinese Society of Clinical Oncology ( CSCO )GU Weijie, ZHU Yao224-2324Progress in adjuvant intensive therapy for triple negative breast cancerCAO Wenming, WANG Xiaojia233-2375Predictive effect of calcyphosine on the prognosis of breast cancerCHEN Xiu, LI Lei, ZHANG Heda, ZHANG Jian238-2436Clinical efficacy of pedicled pectoral fascia flap in immediate prosthesis breast reconstructionHU Qing, LI Jian, GONG Jianping, YU Qiao, DENG Rong244-2477Research progress of phyllodes tumor of the breastTAN Yupei, ZHANG Zichen, ZHANG Dongxiao, SUN Yujian, FU Na, DONG Hao, HUANG Qiao, ZHAO Wenjie, GAO Chang248-2518Research progress of secretory breast carcinomaSONG Yuxin, XU Zheng, XU Di, ZHANG Jian, LI Lei, WANG Dandan, XIAO Xuan, TANG Jinhai252-2569Application of MDT in gynecological malignant tumorsWANG Jinhua257-26110Multidisciplinary teamwork for the diagnosis and treatment of a case of giant renal angiomyolipomaWANG Shu, ZHANG Qiang, QING Chen, HU Chunyan, XIE Liang262-26611A SUVmax model based on 68 Ga-PSMA PET/CT to predict clinically significant prostate cancer in patients with PSA levels <20. 0 μg/LMAO Liang, ZHAO Jun, LI Wencheng, ZHANG Lele, YU Fei, XU Zheng, ZHU Jiageng, SU Jianghao, WANG Feng, SUN Hongbin267-27112Analysis of the value of enhanced MRI texture features in judging different grades ofglioma and isocitrate dehydrogenase gene phenotypeZHANG Yaxuan, WANG Sen, CAO Boqiang, LIU Xuan, XU Xiao, ZHANG Yin272-27713MiR-145-5p regulates the drug resistance of glioma cells to DMC-BH through TCTPCHENG Chao, SUN Guan, SHI Lei278-28414Clinical observation of Calypso system in liver SBRTZHAN Mengna, WEI Xiaowei, HE Xia, YIN Li, FENG Yong285-29015Relationship between circulating tumor cells and clinical characteristics of patients withurothelial carcinomaLIU Jie, MA Cailing, LI Xiaohang, LI An'an, LIU Xin, WANG Zhiyong291-29516Exosomes circ-RPPH1 regulates breast cancer paclitaxel resistance through the circ-RPPH1/miR-146b-3p/ MUC19 axisZHAO Yue, FU Yongqiang, ZHOU Zhenlin, YANG Ming, HUANG Weichao, FANG Yalan296-30617Advances of super enhancers in prostate cancerLONG Jun, CHEN Lin, YANG Yafei, HE Jiangshu, LI Jia, WANG Song, CHEN Shulian, LIANG Guobiao, YANG Jin307-312 